07:44 AM EDT, 08/20/2024 (MT Newswires) -- Exact Sciences ( EXAS ) said on Tuesday the first patient had joined its multi-cancer early detection falcon registry study at Baylor Scott & White, its primary study site in Texas.

The company said the study, involving up to 25,000 patients, would assess the performance, experience, and impact of multi-cancer early detection testing over five years.

It added that Endeavor Health would start patient enrollment from this fall.

Price: 59.90, Change: +0.93, Percent Change: +1.58